References
- Winn SR, Hu Y, Sfeir C, et al. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 2000; 42: 121–38
- Cheng SL, Lou J, Wright NM, et al. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcif Tissue Int 2001; 68: 87–94
- Chen Y, Cheung KM, Kung HF, et al. In vivo new bone formation by direct transfer of adenoviral-mediated bone morphogenetic protein-4 gene. Biochem Biophys Res Commun 2002; 298: 121–7
- Chaudhary LR, Hofmeister AM, Hruska KA. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 2004; 34: 402–11
- Asahina I, Sampath TK, Hauschka PV. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 1996; 222: 38–47
- Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 1999; 81: 905–17
- Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211–28
- De Ugarte DA, Ashjian PH, Elbarbary A, et al. Future of fat as raw material for tissue regeneration. Ann Plast Surg 2003; 50: 215–9
- Gronthos S, Franklin DM, Leddy HA, et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001; 189: 54–63
- Lee JA, Parrett BM, Conejero JA, et al. Biological alchemy: engineering bone and fat from fat-derived stem cells. Ann Plast Surg 2003; 50: 610–7
- Aust L, Devlin B, Foster SJ, et al. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 2004; 6: 7–14
- Animal Care and Use Protocols. In:. Guide for the Care and Use of Laboratory Animals. Commission of Life Sciences, National Research Council. Washington, D.C., National Academy Press, 1996:10
- He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 3(95)2509–14
- Song C, Guo Z, Ma Q, et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003; 308: 458–62
- Gugala Z, Olmsted-Davis EA, Gannon FH, et al. Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Gene Ther 2003; 10: 1289–96
- Hidaka C, Khan SN, Farmer JC, et al. Gene therapy for spinal applications. Orthop Clin North Am 2002; 33: 439–46
- Hannallah D, Peterson B, Lieberman JR, et al. Gene therapy in orthopaedic surgery. J Bone Joint Surg Am 2002; 84A: 1046–61
- Dragoo JL, Choi JY, Lieberman JR, et al. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 2003; 21: 622–9
- Rosen V, Thies RS. The BMP proteins in bone formation and repair. Trends Genet 1992; 8: 97–102
- Li RH, Wozney JM. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 2001; 19: 255–65
- Lee JY, Musgrave D, Pelinkovic D, et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001; 83-A: 1032–9
- Varady P, Li JZ, Cunningham M, et al. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 2001; 10(12)697–710
- Halvorsen YD, Franklin D, Bond AL, et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 2001; 7: 729–41